Vanguard Group’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $22.4K | Hold |
|
|||||
|
2023
Q2 | $16.2K | Hold |
|
|||||
|
2023
Q1 | $15.2K | Sell |
|
|||||
|
2022
Q4 | $41.7K | Hold |
|
|||||
|
2022
Q3 | $50K | Sell |
|
|||||
|
2022
Q2 | $391K | Sell |
|
|||||
|
2022
Q1 | $832K | Buy |
|
|||||
|
2021
Q4 | $621K | Sell |
|
|||||
|
2021
Q3 | $1.97M | Buy |
|
|||||
|
2021
Q2 | $2.48M | Buy |
|
|||||
|
2021
Q1 | $1.9M | Buy |
|
|||||
|
2020
Q4 | $1.01M | Buy |
|
|||||
|
2020
Q3 | $573K | Buy |
|
|||||
|
2020
Q2 | $353K | Buy |
|
|||||
|
2020
Q1 | $144K | Buy |
|
|||||
|
2019
Q4 | $83K | Hold |
|
|||||
|
2019
Q3 | $229K | Sell |
|
|||||
|
2019
Q2 | $490K | Hold |
|
|||||
|
2019
Q1 | $692K | Sell |
|
|||||
|
2018
Q4 | $683K | Sell |
|
|||||
|
2018
Q3 | $933K | Buy |
|
|||||
|
2018
Q2 | $776K | Buy |
|
|||||
|
2018
Q1 | $793K | Buy |
|
|||||
|
2017
Q4 | $822K | Buy |
|
|||||
|
2017
Q3 | $402K | Buy |
|
|||||
|
2017
Q2 | $271K | Sell |
|
|||||
|
2017
Q1 | $490K | Buy |
|
|||||
|
2016
Q4 | $471K | Sell |
|
|||||
|
2016
Q3 | $710K | Sell |
|
|||||
|
2016
Q2 | $1.09M | Buy |
|
|||||
|
2016
Q1 | $925K | Buy |
|
|||||
|
2015
Q4 | $962K | Sell |
|
|||||
|
2015
Q3 | $1.11M | Buy |
|
|||||
|
2015
Q2 | $1.63M | Buy |
|
|||||
|
2015
Q1 | $2.15M | Buy |
|
|||||
|
2014
Q4 | $2.26M | Buy |
|
|||||
|
2014
Q3 | $2.32M | Buy |
|
|||||
|
2014
Q2 | $2.34M | Sell |
|
|||||
|
2014
Q1 | $2.6M | Buy |
|
|||||
|
2013
Q4 | $1.99M | Sell |
|
|||||
|
2013
Q3 | $2.82M | Buy |
|
|||||
|
2013
Q2 | $6.9M | Buy |
|